News


Melanoma: identification of a tumor suppressor function of the Fes protein tyrosine kinase

Category: CRCM Press Releases

 

Paulo de Sepulveda, Patrice Dubreuil and their team at the CRCM reveal, in collaboration with JC Marine at the Université Libre de Bruxelles, a function of the Fes protein in the dissemination of melanoma and the formation of metastases, paving the way to the development of new therapeutic strategies for melanoma by modulating the expression of Fes.

The results of this study were publiqhed in the Journal of Clinical Investigations, and were highlighted in the Science & Santé journal published by Inserm (see attached).